-
1
-
-
36348961924
-
Congenital amegakaryocytic thrombocytopenia: Clinical and biological consequences of five novel mutations
-
Savoia A, Dufour C, Locatelli F, et al. Congenital amegakaryocytic thrombocytopenia: Clinical and biological consequences of five novel mutations. Haematologica 2007; 92:1186-1193.
-
(2007)
Haematologica
, vol.92
, pp. 1186-1193
-
-
Savoia, A.1
Dufour, C.2
Locatelli, F.3
-
2
-
-
81755166539
-
Congenital amegakaryocytic thrombocytopenia: Clinical presentation, diagnosis, and treatment
-
Ballmaier M, Germeshausen M. Congenital amegakaryocytic thrombocytopenia: Clinical presentation, diagnosis, and treatment. Semin Thromb Hemost 2011; 37:673-681.
-
(2011)
Semin Thromb Hemost
, vol.37
, pp. 673-681
-
-
Ballmaier, M.1
Germeshausen, M.2
-
3
-
-
11244283829
-
Cellular immunotherapy for viral infection after HSC transplantation
-
Moss P, Rickinson A. Cellular immunotherapy for viral infection after HSC transplantation. Nat Rev Immunol 2005; 5:9-20.
-
(2005)
Nat Rev Immunol
, vol.5
, pp. 9-20
-
-
Moss, P.1
Rickinson, A.2
-
4
-
-
52649179836
-
Cytotoxic T lymphocytes as immune-therapy in haematological practice
-
Leen AM, Heslop HE. Cytotoxic T lymphocytes as immune-therapy in haematological practice. Br J Haematol 2008; 143:169-179.
-
(2008)
Br J Haematol
, vol.143
, pp. 169-179
-
-
Leen, A.M.1
Heslop, H.E.2
-
5
-
-
33645303196
-
Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: The Extracorporeal Life Support Organization experience
-
Gow KW, Wulkan ML, Heiss KF, et al. Extracorporeal membrane oxygenation for support of children after hematopoietic stem cell transplantation: The Extracorporeal Life Support Organization experience. J Pediatr Surg 2006; 41:662-667.
-
(2006)
J Pediatr Surg
, vol.41
, pp. 662-667
-
-
Gow, K.W.1
Wulkan, M.L.2
Heiss, K.F.3
-
6
-
-
84864075455
-
Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan
-
Bernardo ME, Piras E, Vacca A, et al. Allogeneic hematopoietic stem cell transplantation in thalassemia major: Results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood 2012; 120:473-476.
-
(2012)
Blood
, vol.120
, pp. 473-476
-
-
Bernardo, M.E.1
Piras, E.2
Vacca, A.3
-
7
-
-
78650489175
-
How I treat adenovirus in hematopoietic stem cell transplant recipients
-
Lindemans CA, Leen AM, Boelens JJ. How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 2010; 116:5476-5485.
-
(2010)
Blood
, vol.116
, pp. 5476-5485
-
-
Lindemans, C.A.1
Leen, A.M.2
Boelens, J.J.3
-
8
-
-
0033963020
-
+ cells: Analysis of predictive factors and comparison with unselected progenitor transplants
-
+ cells: Analysis of predictive factors and comparison with unselected progenitor transplants. Br J Haematol 2000; 108:105-115.
-
(2000)
Br J Haematol
, vol.108
, pp. 105-115
-
-
Rutella, S.1
Rumi, C.2
Laurenti, L.3
-
9
-
-
84870975363
-
European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: Summary of ECIL-4 (2011)
-
Matthes-Martin S, Feuchtinger T, Shaw PJ, et al. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: Summary of ECIL-4 (2011). Transpl Infect Dis 2012; 14:555-563.
-
(2012)
Transpl Infect Dis
, vol.14
, pp. 555-563
-
-
Matthes-Martin, S.1
Feuchtinger, T.2
Shaw, P.J.3
-
10
-
-
70349755660
-
Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host
-
Li Pira G, Kapp M, Manca F, et al. Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host. Curr Opin Immunol 2009; 21:549-556.
-
(2009)
Curr Opin Immunol
, vol.21
, pp. 549-556
-
-
Li Pira, G.1
Kapp, M.2
Manca, F.3
-
11
-
-
83755188603
-
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
-
Sili U, Leen AM, Vera JF, et al. Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant. Cytotherapy 2012; 14:7-11.
-
(2012)
Cytotherapy
, vol.14
, pp. 7-11
-
-
Sili, U.1
Leen, A.M.2
Vera, J.F.3
-
12
-
-
33744788680
-
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
-
Feuchtinger T, Matthes-Martin S, Richard C, et al. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol 2006; 134:64-76.
-
(2006)
Br J Haematol
, vol.134
, pp. 64-76
-
-
Feuchtinger, T.1
Matthes-Martin, S.2
Richard, C.3
-
13
-
-
78549241330
-
Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation
-
Feuchtinger T, Opherk K, Bethge WA, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 2010; 116:4360-4367.
-
(2010)
Blood
, vol.116
, pp. 4360-4367
-
-
Feuchtinger, T.1
Opherk, K.2
Bethge, W.A.3
-
14
-
-
44949186579
-
Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation
-
Feuchtinger T, Richard C, Joachim S, et al. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation. J Immunother 2008; 31:199-206.
-
(2008)
J Immunother
, vol.31
, pp. 199-206
-
-
Feuchtinger, T.1
Richard, C.2
Joachim, S.3
-
15
-
-
1542267415
-
+ T cells according to IFN-γ secretion for adjuvant immunotherapy
-
+ T cells according to IFN-γ secretion for adjuvant immunotherapy. Exp Hematol 2004; 32:282-289.
-
(2004)
Exp Hematol
, vol.32
, pp. 282-289
-
-
Feuchtinger, T.1
Lang, P.2
Hamprecht, K.3
-
16
-
-
78149249171
-
+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
-
+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica 2010; 95:1943-1951.
-
(2010)
Haematologica
, vol.95
, pp. 1943-1951
-
-
Zandvliet, M.L.1
Falkenburg, J.H.2
van Liempt, E.3
-
17
-
-
33745616804
-
low/neg accessory cells with dendritic-cell features
-
low/neg accessory cells with dendritic-cell features. Blood 2006; 108:218-227.
-
(2006)
Blood
, vol.108
, pp. 218-227
-
-
Rutella, S.1
Bonanno, G.2
Procoli, A.3
|